By expenditures
| Name | Title | Type |
|---|---|---|
| Kimberly Marshall | Managing Director | Auditee |
| Mireya Perez | Chief Financial Officer | Auditee |
| Keith McLaughlin | PROVOST | Auditee |
| Kimberly Marshall | Managing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 345382 | 2024 | 2025-03-10 | Forvis Mazars LLP | $9.52M |
| 294656 | 2023 | 2024-03-12 | Forvis LLP | $15.01M |
| 26790 | 2022 | 2023-02-05 | Forvis LLP | $15.46M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 345382 | 2024 | 2025-03-10 | 1102903 | 2024-002 | Significant Deficiency | Yes | N |
| 345382 | 2024 | 2025-03-10 | 1102902 | 2024-002 | Significant Deficiency | Yes | N |
| 345382 | 2024 | 2025-03-10 | 1102901 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 1102900 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 1102899 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 1102898 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 526461 | 2024-002 | Significant Deficiency | Yes | N |
| 345382 | 2024 | 2025-03-10 | 526460 | 2024-002 | Significant Deficiency | Yes | N |
| 345382 | 2024 | 2025-03-10 | 526459 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 526458 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 526457 | 2024-001 | - | Yes | N |
| 345382 | 2024 | 2025-03-10 | 526456 | 2024-001 | - | Yes | N |
| 294656 | 2023 | 2024-03-12 | 952024 | 2023-003 | Material Weakness | - | N |
| 294656 | 2023 | 2024-03-12 | 952023 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 952022 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 952021 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 952020 | 2023-003 | Material Weakness | - | N |
| 294656 | 2023 | 2024-03-12 | 952019 | 2023-002 | Significant Deficiency | - | L |
| 294656 | 2023 | 2024-03-12 | 952018 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 375582 | 2023-003 | Material Weakness | - | N |
| 294656 | 2023 | 2024-03-12 | 375581 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 375580 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 375579 | 2023-001 | - | - | N |
| 294656 | 2023 | 2024-03-12 | 375578 | 2023-003 | Material Weakness | - | N |
| 294656 | 2023 | 2024-03-12 | 375577 | 2023-002 | Significant Deficiency | - | L |
| 294656 | 2023 | 2024-03-12 | 375576 | 2023-001 | - | - | N |